Home›Companies›Biotech & Pharma›Vernal Biosciences

Vernal Biosciences, Inc.

Updated Oct 27, 2026·Latest SEC filing Jun 16, 2023·Suggest an edit

About Vernal Biosciences

Vernal Biosciences is a private company based in Colchester, Vermont, incorporated in 2020 in Delaware. It has reported $42,498,390 raised in two offerings on Form D since May 2021.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 10, 2022May 25, 2022amended Jun 16, 2023$40,998,390fully sold10$4.0MEquityRule 506(b)Form D/A ↗1 earlier filing
Apr 6, 2021May 24, 2021$1,500,000fully sold9$166KEquityRule 506(b)Form D ↗
Total, two offerings$42,498,390

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Vernal Biosciences's Form D filed Jun 16, 2023.

DA
CC
Christian Cobaugh
President and director

Earlier filings also listed Errik Anderson (director, last listed May 2021).

Sources

  1. SECVernal Biosciences, Inc. Form D, filed May 25, 2022
  2. SECVernal Biosciences, Inc. filing history